Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?

× No keyword cloud information.

6 in total

1. Urgent monitoring of direct oral anticoagulants in patients with atrial fibrillation: a tentative approach based on routine laboratory tests.

Authors: Giuseppe Lippi; Diego Ardissino; Roberto Quintavalla; Gianfranco Cervellin
Journal: J Thromb Thrombolysis Date: 2014 Impact factor: 2.300

2. What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time?

Authors: Mesude Falay; Mehmet Senes; Dogan Yücel; Turan Turhan; Simten Dagdaş; Melike Pekin; Namik K Nazaroglu; Gülsüm Özet
Journal: J Clin Lab Anal Date: 2018-02-27 Impact factor: 2.352

3. Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability.

Authors: Job Harenberg; Roland Krämer; Christina Giese; Svetlana Marx; Christel Weiss; Martin Wehling
Journal: J Thromb Thrombolysis Date: 2011-10 Impact factor: 2.300

Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?

1. Urgent monitoring of direct oral anticoagulants in patients with atrial fibrillation: a tentative approach based on routine laboratory tests.

2. What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time?

3. Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability.

4. Concept of a point of care test to detect new oral anticoagulants in urine samples.

Review 5. The new oral anticoagulants and the future of haemostasis laboratory testing.

Review 6. Anticoagulants and acute kidney injury: clinical and pathology considerations.